medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2006, Número 3

<< Anterior Siguiente >>

Ann Hepatol 2006; 5 (3)


Effect of pregnancy on pre-existing liver disease: Chronic viral hepatitis

Sookoian S

Idioma: Ingles.
Referencias bibliográficas: 78
Paginas: 190-197
Archivo PDF: 109.07 Kb.


FRAGMENTO

Sin resumen


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Lee C, Gong Y, Brok J, Boxall EH, Gluud C. Effect of hepatitis B immunisation in newborn infants of mothers positive for hepatitis B surface antigen: systematic review and meta-analysis. BMJ 2006; 11; 332(7537): 328-336.

  2. Schaefer E, Koeppen H, Wirth S. Low level virus replication in infants with vertically transmitted fulminant hepatitis and their anti-HBe positive mothers. Eur J Pediatr 1993; 152(7): 581-584.

  3. Ohto H, Terazawa S, Sasaki N, Sasaki N, Hino K, Ishiwata C, et al. Transmission of hepatitis C virus from mothers to infants. The Vertical Transmission of Hepatitis C Virus Collaborative Study Group. N Engl J Med 1994; 17; 330(11): 744-750.

  4. Tajiri H, Miyoshi Y, Funada S, Etani Y, Abe J, Onodera T, et al. Prospective study of mother-to-infant transmission of hepatitis C virus. Pediatr Infect Dis J 2001; 20(1): 10-14.

  5. Thomas SL, Newell ML, Peckham CS, Ades AE, Hall AJ. A review of hepatitis C virus (HCV) vertical transmission: risks of transmission to infants born to mothers with and without HCV viraemia or human immunodeficiency virus infection. Int J Epidemiol 1998; 27(1): 108-117.

  6. Ghendon Y. Perinatal transmission of hepatitis B virus in high-incidence countries. J Virol Methods 1987; 17(1-2): 69-79.

  7. Gibb DM, Goodall RL, Dunn DT, Healy M, Neave P, Cafferkey M, et al. Mother-to-child transmission of hepatitis C virus: evidence for preventable peripartum transmission. Lancet 2000; 9; 356(9233): 904-907.

  8. Steininger C, Kundi M, Jatzko G, Kiss H, Lischka A, Holzmann H. Increased risk of mother-to-infant transmission of hepatitis C virus by intrapartum infantile exposure to maternal blood. J Infect Dis 2003; 1; 187(3): 345-351.

  9. Mok J, Pembrey L, Tovo PA, Newell ML. When does mother to child transmission of hepatitis C virus occur? Arch Dis Child Fetal Neonatal Ed 2005; 90(2): F156-F160.

  10. Resti M, Azzari C, Mannelli F, Moriondo M, Novembre E, de MM, et al. Mother to child transmission of hepatitis C virus: prospective study of risk factors and timing of infection in children born to women seronegative for HIV-1. Tuscany Study Group on Hepatitis C Virus Infection. BMJ 1998; 15; 317(7156): 437-441.

  11. Vranckx R, Alisjahbana A, Meheus A. Hepatitis B virus vaccination and antenatal transmission of HBV markers to neonates. J Viral Hepat 1999; 6(2): 135-139.

  12. Lin HH, Lee TY, Chen DS, Sung JL, Ohto H, Etoh T, et al. Transplacental leakage of HBeAg-positive maternal blood as the most likely route in causing intrauterine infection with hepatitis B virus. J Pediatr 1987; 111(6 Pt 1): 877-881.

  13. Xu DZ, Yan YP, Choi BC, Xu JQ, Men K, Zhang JX, et al. Risk factors and mechanism of transplacental transmission of hepatitis B virus: a case-control study. J Med Virol 2002; 67(1): 20-26.

  14. Tang JR, Hsu HY, Lin HH, Ni YH, Chang MH. Hepatitis B surface antigenemia at birth: a long-term follow-up study. J Pediatr 1998; 133(3): 374-377.

  15. Soderstrom A, Norkrans G, Lindh M. Hepatitis B virus DNA during pregnancy and post partum: aspects on vertical transmission. Scand J Infect Dis 2003; 35(11-12): 814-819.

  16. Burk RD, Hwang LY, Ho GY, Shafritz DA, Beasley RP. Outcome of perinatal hepatitis B virus exposure is dependent on maternal virus load. J Infect Dis 1994; 170(6): 1418-1423.

  17. Raimondo G, Tanzi E, Brancatelli S, Campo S, Sardo MA, Rodino G, et al. Is the course of perinatal hepatitis B virus infection influenced by genetic heterogeneity of the virus? J Med Virol 1993; 40(2):87-90.

  18. Ngui SL, Andrews NJ, Underhill GS, Heptonstall J, Teo CG. Failed postnatal immunoprophylaxis for hepatitis B: characteristics of maternal hepatitis B virus as risk factors. Clin Infect Dis 1998; 27(1): 100-106.

  19. Mast EE, Hwang LY, Seto DS, Nolte FS, Nainan OV, Wurtzel H, et al. Risk factors for perinatal transmission of hepatitis C virus (HCV) and the natural history of HCV infection acquired in infancy. J Infect Dis 2005; 1; 192(11): 1880-1889.

  20. Zuccotti GV, Ribero ML, Giovannini M, Fasola M, Riva E, Portera G, et al. Effect of hepatitis C genotype on mother-to-infant transmission of virus. J Pediatr 1995; 127(2): 278-280.

  21. Azzari C, Resti M, Moriondo M, Ferrari R, Lionetti P, Vierucci A. Vertical transmission of HCV is related to maternal peripheral blood mononuclear cell infection. Blood 2000; 15; 96(6): 2045-2048.

  22. Resti M, Azzari C, Galli L, Zuin G, Giacchino R, Bortolotti F, et al. Maternal drug use is a preeminent risk factor for mother-to-child hepatitis C virus transmission: results from a multicenter study of 1372 mother-infant pairs. J Infect Dis 2002; 1; 185(5): 567-572.

  23. Indolfi G, Azzari C, Moriondo M, Lippi F, de MM, Resti M. Alanine transaminase levels in the year before pregnancy predict the risk of hepatitis C virus vertical transmission. J Med Virol 2006; 78(7): 911-914.

  24. Spencer JD, Latt N, Beeby PJ, Collins E, Saunders JB, McCaughan GW, et al. Transmission of hepatitis C virus to infants of human immunodeficiency virus-negative intravenous drug-using mothers: rate of infection and assessment of risk factors for transmission. J Viral Hepat 1997; 4(6): 395-409.

  25. Gervais A, Bacq Y, Bernuau J, Martinot M, Auperin A, Boyer N, et al. Decrease in serum ALT and increase in serum HCV RNA during pregnancy in women with chronic hepatitis C. J Hepatol 2000; 32(2): 293-299.

  26. Wejstal R, Widell A, Norkrans G. HCV-RNA levels increase during pregnancy in women with chronic hepatitis C. Scand J Infect Dis 1998; 30(2): 111-113.

  27. Paternoster DM, Santarossa C, Grella P, Palu G, Baldo V, Boccagni P, et al. Viral load in HCV RNA-positive pregnant women. Am J Gastroenterol 2001; 96(9): 2751-2754.

  28. Hattori Y, Orito E, Ohno T, Sugauchi F, Suzuki S, Sugiura M, et al. Loss of hepatitis C virus RNA after parturition in female patients with chronic HCV infection. J Med Virol 2003; 71(2): 205-211.

  29. Conte D, Fraquelli M, Prati D, Colucci A, Minola E. Prevalence and clinical course of chronic hepatitis C virus (HCV) infection and rate of HCV vertical transmission in a cohort of 15,250 pregnant women. Hepatology 2000; 31(3): 751-755.

  30. Sangfelt P, Von SM, Uhnoo I, Weiland O, Lindh G, Fischler B, et al. Serum ALT levels as a surrogate marker for serum HBV DNA levels in HBeAg-negative pregnant women. Scand J Infect Dis 2004; 36(3): 182-185.

  31. Lee SD, Lo KJ, Tsai YT, Wu JC, Wu TC, Yang ZL, et al. Role of caesarean section in prevention of mother-infant transmission of hepatitis B virus. Lancet 1988; 8; 2(8615): 833-834.

  32. Wang J, Zhu Q, Zhang X. Effect of delivery mode on maternal-infant transmission of hepatitis B virus by immunoprophylaxis. Chin Med J (Engl) 2002; 115(10): 1510-1512.

  33. Sexually transmitted diseases treatment guidelines 2002. Centers for Disease Control and Prevention. MMWR Recomm Rep 2002; 10; 51(RR-6): 1-78.

  34. Davies G, Wilson RD, Desilets V, Reid GJ, Shaw D, Summers A, et al. Amniocentesis and women with hepatitis B, hepatitis C, or human immunodeficiency virus. J Obstet Gynaecol Can 2003; 25(2): 145-152.

  35. A significant sex-but not elective cesarean section-effect on motherto-child transmission of hepatitis C virus infection. J Infect Dis 2005; 1; 192(11): 1872-1879.

  36. Paccagnini S, Principi N, Massironi E, Tanzi E, Romano L, Muggiasca ML, et al. Perinatal transmission and manifestation of hepatitis C virus infection in a high risk population. Pediatr Infect Dis J 1995; 14(3): 195-199.

  37. Ghendon Y. WHO strategy for the global elimination of new cases of hepatitis B. Vaccine 1990; 8 Suppl: S129-S133.

  38. Mast EE, Margolis HS, Fiore AE, Brink EW, Goldstein ST, Wang SA, et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents. MMWR Recomm Rep 2005; 23; 54(RR-16): 1-31.

  39. Atkinson WL, Pickering LK, Schwartz B, Weniger BG, Iskander JK, Watson JC. General recommendations on immunization. Recommendations of the Advisory Committee on Immunization Practices (ACIP) and the American Academy of Family Physicians (AAFP). MMWR Recomm Rep 2002; 8; 51(RR-2): 1-35.

  40. Wang JS, Zhu QR, Wang XH. Breastfeeding does not pose any additional risk of immunoprophylaxis failure on infants of HBV carrier mothers. Int J Clin Pract 2003; 57(2): 100-102.

  41. Hsu HY, Chang MH, Ni YH, Lin HH, Wang SM, Chen DS. Surface gene mutants of hepatitis B virus in infants who develop acute or chronic infections despite immunoprophylaxis. Hepatology 1997; 26(3): 786-791.

  42. Ward C, Tudor-Williams G, Cotzias T, Hargreaves S, Regan L, Foster GR. Prevalence of hepatitis C among pregnant women attending an inner London obstetric department: uptake and acceptability of named antenatal testing. Gut 2000; 47(2): 277-280.

  43. Hill JB, Sheffield JS, Kim MJ, Alexander JM, Sercely B, Wendel GD. Risk of hepatitis B transmission in breast-fed infants of chronic hepatitis B carriers. Obstet Gynecol 2002; 99(6): 1049-1052.

  44. Boxall EH, Flewett TH, Dane DS, Cameron CH, MacCallum FO, Lee TW. Letter: Hepatitis-B surface antigen in breast milk. Lancet 1974; 26; 2(7887): 1007-1008.

  45. Linnemann CC, Jr., Goldberg S. Letter: HBAg in breast milk. Lancet 1974; 20; 2(7873): 155.

  46. Woo D, Cummins M, Davies PA, Harvey DR, Hurley R, Waterson AP. Vertical transmission of hepatitis B surface antigen in carrier mothers in two west London hospitals. Arch Dis Child 1979; 54(9): 670-675.

  47. Chen DS, Hsu NH, Sung JL, Hsu TC, Hsu ST, Kuo YT, et al. A mass vaccination program in Taiwan against hepatitis B virus infection in infants of hepatitis B surface antigen-carrier mothers. JAMA 1987; 15; 257(19): 2597-2603.

  48. ACOG committee opinion. Breastfeeding and the risk of hepatitis C virus transmission. Number 220, August 1999. Committee on Obstetric Practice. American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet 1999; 66(3): 307-308.

  49. Ruiz-Extremera A, Salmeron J, Torres C, De Rueda PM, Gimenez F, Robles C, et al. Follow-up of transmission of hepatitis C to babies of human immunodeficiency virus-negative women: the role of breastfeeding in transmission. Pediatr Infect Dis J 2000; 19(6): 511-516.

  50. Kumar RM, Shahul S. Role of breast-feeding in transmission of hepatitis C virus to infants of HCV-infected mothers. J Hepatol 1998; 29(2): 191-197.

  51. Hiratsuka M, Minakami H, Koshizuka S, Sato I. Administration of interferon-alpha during pregnancy: effects on fetus. J Perinat Med 2000; 28(5): 372-376.

  52. Fritz M, Vats K, Goyal RK. Neonatal lupus and IUGR following alpha-interferon therapy during pregnancy. J Perinatol 2005; 25(8): 552-554.

  53. Chard T. Interferon in pregnancy. J Dev Physiol 1989; 11(5): 271-276.

  54. Nephew KP, McClure KE, Day ML, Xie S, Roberts RM, Pope WF. Effects of intramuscular administration of recombinant bovine interferon-alpha I1 during the period of maternal recognition of pregnancy. J Anim Sci 1990; 68(9): 2766-2770.

  55. Trotter JF, Zygmunt AJ. Conception and pregnancy during interferonalpha therapy for chronic hepatitis C. J Clin Gastroenterol 2001; 32(1): 76-78.

  56. Trasler JM, Doerksen T. Teratogen update: paternal exposures-reproductive risks. Teratology 1999; 60(3): 161-172.

  57. Maddrey WC. Safety of combination interferon alfa-2b/ribavirin therapy in chronic hepatitis C-relapsed and treatment-naive patients. Semin Liver Dis 1999; 19 Suppl 1: 67-75.

  58. Taguchi N, Ito S. Paternal use of ribavirin-interferon alpha 2B combination therapy before conception. Can Fam Physician 2005; 51: 1623-1625.

  59. van Zonneveld M, van Nunen AB, Niesters HG, de Man RA, Schalm SW, Janssen HL. Lamivudine treatment during pregnancy to prevent perinatal transmission of hepatitis B virus infection. J Viral Hepat 2003; 10(4): 294-297.

  60. Su GG, Pan KH, Zhao NF, Fang SH, Yang DH, Zhou Y. Efficacy and safety of lamivudine treatment for chronic hepatitis B in pregnancy. World J Gastroenterol 2004; 15; 10(6): 910-912.

  61. Moodley J, Moodley D, Pillay K, Coovadia H, Saba J, van Leeuwen R, et al. Pharmacokinetics and antiretroviral activity of lamivudine alone or when coadministered with zidovudine in human immunodeficiency virus type 1-infected pregnant women and their offspring. J Infect Dis 1998; 178(5): 1327-1333.

  62. Kazim SN, Wakil SM, Khan LA, Hasnain SE, Sarin SK. Vertical transmission of hepatitis B virus despite maternal lamivudine therapy. Lancet 2002; 27; 359(9316): 1488-1489.

  63. Divi RL, Leonard SL, Kuo MM, Walker BL, Orozco CC, St Claire MC, et al. Cardiac mitochondrial compromise in 1-yr-old Erythrocebus patas monkeys perinatally-exposed to nucleoside reverse transcriptase inhibitors. Cardiovasc Toxicol 2005; 5(3): 333-346.

  64. Tse KY, Ho LF, Lao T. The impact of maternal HBsAg carrier status on pregnancy outcomes: a case-control study. J Hepatol 2005; 43(5): 771-775.

  65. Hieber JP, Dalton D, Shorey J, Combes B. Hepatitis and pregnancy. J Pediatr 1977; 91(4): 545-549.

  66. Pavel A, Tirsia E, Maior E, Cristea A. Detrimental effects of hepatitis B virus infection on the development of the product of conception. Virologie 1983; 34(1): 35-40.

  67. Su WH, Wang PH, Yuan CC, Chang SP. Fetal meconium peritonitis in the infant of a woman with fulminant hepatitis B. A case report. J Reprod Med 2002; 47(11): 952-954.

  68. Jhaveri RC, Verma RS, Rosenfeld W, Salazar DJ, Dosik H, Evans HE. Chromosomal abnormality in the newborns of hepatitis B surface antigen (HBsAg) carrier mothers. Clin Pediatr (Phila) 1980; 19(1): 66-68.

  69. Lao TT, Tse KY, Chan LY, Tam KF, Ho LF. HBsAg carrier status and the association between gestational diabetes with increased serum ferritin concentration in Chinese women. Diabetes Care 2003; 26(11): 3011-3016.

  70. Jaffery T, Tariq N, Ayub R, Yawar A. Frequency of hepatitis C in pregnancy and pregnancy outcome. J Coll Physicians Surg Pak 2005; 15(11): 716-719.

  71. Jabeen T, Cannon B, Hogan J, Crowley M, Devereux C, Fanning L, et al. Pregnancy and pregnancy outcome in hepatitis C type 1b. QJM 2000; 93(9): 597-601.

  72. Floreani A, Paternoster D, Zappala F, Cusinato R, Bombi G, Grella P, et al. Hepatitis C virus infection in pregnancy. Br J Obstet Gynaecol 1996; 103(4): 325-329.

  73. Paternoster DM, Fabris F, Palu G, Santarossa C, Bracciante R, Snijders D, et al. Intra-hepatic cholestasis of pregnancy in hepatitis C virus infection. Acta Obstet Gynecol Scand 2002; 81(2): 99-103.

  74. Ko TM, Tseng LH, Chang MH, Chen DS, Hsieh FJ, Chuang SM, et al. Amniocentesis in mothers who are hepatitis B virus carriers does not expose the infant to an increased risk of hepatitis B virus infection. Arch Gynecol Obstet 1994; 255(1): 25-30.

  75. Minola E, Maccabruni A, Pacati I, Martinetti M. Amniocentesis as a possible risk factor for mother-to-infant transmission of hepatitis C virus. Hepatology 2001; 33(5): 1341-1342.

  76. Berry WR, Gottesfeld RL, Alter HJ, Vierling JM. Transmission of hepatitis B virus by artificial insemination. JAMA 1987; 257(8): 1079-1081.

  77. Lesourd F, Izopet J, Mervan C, Payen JL, Sandres K, Monrozies X, et al. Transmissions of hepatitis C virus during the ancillary procedures for assisted conception. Hum Reprod 2000; 15(5): 1083-1085.

  78. McKee TA, Avery S, Majid A, Brinsden PR. Risks for transmission of hepatitis C virus during artificial insemination. Fertil Steril 1996; 66(1): 161-163.




2020     |     www.medigraphic.com